Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis

被引：0
|
作者：
Sizheng Zhao
Laura Chadwick
Eduardo Mysler
Robert J. Moots
机构：
[1] University of Liverpool,Department of Musculoskeletal Biology I, Clinical Sciences Centre, Institute of Ageing and Chronic Disease
[2] Aintree University Hospital,undefined
[3] Organización Medica de Investigación,undefined
来源：
Current Rheumatology Reports | 2018年 / 20卷
关键词：
Adalimumab; Biosimilar; Rheumatoid arthritis; Amgevita; Cyltezo; Imraldi;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
    Zhao, Sizheng
    Chadwick, Laura
    Mysler, Eduardo
    Moots, Robert J.
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [2] Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
    Chadwick, Laura
    Zhao, Sizheng
    Mysler, Eduardo
    Moots, Robert J.
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (12)
  • [3] Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
    Laura Chadwick
    Sizheng Zhao
    Eduardo Mysler
    Robert J. Moots
    Current Rheumatology Reports, 2018, 20
  • [4] Real-Life Tolerability and Effectiveness of Adalimumab Biosimilar in Rheumatoid Arthritis: ASPIRE Registry Data
    Kapoor, Sanjiv
    Kaushik, Viswanath V.
    Jain, Rahul
    Rao, Vijay
    Gharia, Mihir
    RHEUMATOLOGY AND THERAPY, 2019, 6 (03) : 451 - 459
  • [5] Real-Life Tolerability and Effectiveness of Adalimumab Biosimilar in Rheumatoid Arthritis: ASPIRE Registry Data
    Sanjiv Kapoor
    Viswanath V. Kaushik
    Rahul Jain
    Vijay Rao
    Mihir Gharia
    Rheumatology and Therapy, 2019, 6 : 451 - 459
  • [6] Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
    Sang-Cheol Bae
    Young Ho Lee
    Clinical Rheumatology, 2018, 37 : 1199 - 1205
  • [7] Leukocytoclastic vasculitis induced by adalimumab biosimilar in an elderly female with rheumatoid arthritis: A case-based review
    Mohamadzadeh, Dena
    Assar, Shirin
    Farsad, Faraneh
    EGYPTIAN RHEUMATOLOGIST, 2023, 45 (03) : 225 - 228
  • [8] Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
    Bae, Sang-Cheol
    Lee, Young Ho
    CLINICAL RHEUMATOLOGY, 2018, 37 (05) : 1199 - 1205
  • [9] Adalimumab - A review of its use in rheumatoid arthritis
    Bang, LM
    Keating, GM
    BIODRUGS, 2004, 18 (02) : 121 - 139
  • [10] A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis
    Roy M. Fleischmann
    Rieke Alten
    Margarita Pileckyte
    Kasia Lobello
    Steven Y. Hua
    Carol Cronenberger
    Daniel Alvarez
    Amy E. Bock
    K. Lea Sewell
    Arthritis Research & Therapy, 20
12345